Roche: Keytruda approved in advanced lung cancer

BUY-Top Picks, Fair Value CHF327 (+28%)
News published on October Monday 5, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities